A recent systematic review assessed the oncological outcomes of segmental colectomy and proctocolectomy in patients with IBD-associated colorectal cancer and dysplasia. The review included nine retrospective studies, analyzing outcomes for 4181 patients.
Key findings:
Low rates of missed synchronous cancers (0.5–4.5%) and metachronous cancers (0–33%).
Comparable overall survival rates between segmental colectomy and proctocolectomy.
Postoperative colitis flares requiring medical therapy were common in both groups.
Surgical outcomes such as hospital stay duration, complication rates, and readmission rates were similar for both procedures.
Implications for practice:
Segmental colectomy can be considered a viable option for select patients, offering a less radical alternative without compromising oncological outcomes.
Discussing these findings with patients can aid in shared decision-making, ensuring informed consent and personalized treatment plans.
For more detailed information, refer to the full study: https://doi.org/10.1093/bjsopen/zrae052
Leave a Reply